{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:55:26Z","timestamp":1790805326979,"version":"4.1.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.UMSHA.REC.1400.771"],"award-info":[{"award-number":["IR.UMSHA.REC.1400.771"]}],"id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07755-w","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T13:03:44Z","timestamp":1659013424000},"page":"10865-10874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neuroprotective effect of geraniol on neurological disorders: a review article"],"prefix":"10.1007","volume":"49","author":[{"given":"Shokufeh","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ramezani-Aliakbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Kourosh-Arami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3865-9583","authenticated-orcid":false,"given":"Alireza","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"7755_CR1","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0426-7_ch1","volume-title":"Global priorities for addressing the burden of mental, neurological, and substance use disorders","author":"V Patel","year":"2016","unstructured":"Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T et al (2016) Global priorities for addressing the burden of mental, neurological, and substance use disorders. World Bank, Washington"},{"key":"7755_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-019-0552-7","volume":"21","author":"P Zis","year":"2019","unstructured":"Zis P, Hadjivassiliou M (2019) Treatment of neurological manifestations of gluten sensitivity and coeliac disease. Curr Treat Options Neurol 21:1\u201310","journal-title":"Curr Treat Options Neurol"},{"key":"7755_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-981-16-8158-5_7","volume-title":"Role of nutrients in neurological disorders","author":"A Arumugam","year":"2022","unstructured":"Arumugam A, Thiyagarajan D (2022) Role of nutrition in pathogenesis of neurological disorders. Role of nutrients in neurological disorders. Springer, Singapore, pp 143\u201358"},{"key":"7755_CR4","unstructured":"Organization WH (2006) Neurological disorders: public health challenges. World Health Organization."},{"key":"7755_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/09553002.2021.1988183","volume":"98","author":"JD Boice Jr","year":"2022","unstructured":"Boice JD Jr, Quinn B, Al-Nabulsi I, Ansari A, Blake PK, Blattnig SR et al (2022) A million persons, a million dreams: a vision for a national center of radiation epidemiology and biology. Int J Radiat Biol 98:795\u2013821","journal-title":"Int J Radiat Biol"},{"key":"7755_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1515\/REVEH.2009.24.1.15","volume":"24","author":"T Sanders","year":"2009","unstructured":"Sanders T, Liu Y, Buchner V, Tchounwou PB (2009) Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 24:15\u201346","journal-title":"Rev Environ Health"},{"key":"7755_CR7","doi-asserted-by":"publisher","first-page":"i31","DOI":"10.1136\/jnnp.2004.060459","volume":"76","author":"C Butler","year":"2005","unstructured":"Butler C, Zeman A (2005) Neurological syndromes which can be mistaken for psychiatric conditions. J Neurol Neurosurg Psychiatry 76:i31\u2013i38","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7755_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbrc.2013.09.122","volume":"440","author":"KR Rekha","year":"2013","unstructured":"Rekha KR, Selvakumar GP, Santha K, Sivakamasundari RI (2013) Geraniol attenuates \u03b1-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner. Biochem Biophys Res Commun 440:664\u2013670","journal-title":"Biochem Biophys Res Commun"},{"key":"7755_CR9","volume-title":"Ullmann\u2019s encyclopedia of industrial chemistry","author":"M Eggersdorfer","year":"2000","unstructured":"Eggersdorfer M (2000) Terpenes. Ullmann\u2019s encyclopedia of industrial chemistry. Wiley-VCH, Weinheim"},{"key":"7755_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1051\/apido:19900403","volume":"21","author":"R Danka","year":"1990","unstructured":"Danka R, Williams J, Rinderer T (1990) A bait station for survey and detection of honey bees. Apidologie 21:287\u2013292","journal-title":"Apidologie"},{"key":"7755_CR11","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/molecules27082519","volume":"27","author":"GA Pena","year":"2022","unstructured":"Pena GA, da Costa Lopes AS, de Morais SHS, do Nascimento LD, Dos Santos FRR, da Costa KS et al (2022) Host-guest inclusion complexes of natural products and nanosystems: applications in the development of repellents. Molecules 27:2519","journal-title":"Molecules"},{"key":"7755_CR12","doi-asserted-by":"publisher","first-page":"e0236162","DOI":"10.1371\/journal.pone.0236162","volume":"15","author":"L Hagberg","year":"2020","unstructured":"Hagberg L, Price RW, Zetterberg H, Fuchs D, Gissl\u00e9n M (2020) Herpes zoster in HIV-1 infection: the role of CSF pleocytosis in secondary CSF escape and discordance. PLoS ONE 15:e0236162","journal-title":"PLoS ONE"},{"key":"7755_CR13","first-page":"638","volume":"50","author":"G Stork","year":"1988","unstructured":"Stork G, Grieco P, Gregson M (1988) Allylic chlorides from allylic alcohols-geranyl chloride. Org Synth 50:638\u2013640","journal-title":"Org Synth"},{"key":"7755_CR14","first-page":"634","volume":"50","author":"JG Calzada","year":"1988","unstructured":"Calzada JG, Hooz J (1988) Geranyl chloride. Org Synth 50:634\u2013637","journal-title":"Org Synth"},{"key":"7755_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/0471264180.os072.10","volume-title":"Organic syntheses","author":"H Takaya","year":"2003","unstructured":"Takaya H, Ohta T, Si Inoue, Tokunaga M, Kitamura M, Noyori R (2003) Asymmetric hydrogenation of allylic alcohols using BINAP-ruthenium complexes: (S)-(\u2212)-citronellol: 6-octen-1-ol, 3, 7-dimethyl, (S)-. Organic syntheses. John Wiley & Sons Inc, Hoboken, pp 74\u201374"},{"key":"7755_CR16","first-page":"18","volume":"83","author":"G Piancatelli","year":"2003","unstructured":"Piancatelli G, Leonelli F (2003) Oxidation of nerol to neral with iodosobenzene and TEMPO [(Z)-3, 7-Dimethyl-2, 6-octadienal]. Org Synth 83:18\u201323","journal-title":"Org Synth"},{"key":"7755_CR17","first-page":"367","volume":"19","author":"S Hinger","year":"2010","unstructured":"Hinger S (2010) Finding the fundamental: shaping identity in gender and sexual orientation based asylum claims. Colum J Gender L 19:367","journal-title":"Colum J Gender L"},{"key":"7755_CR18","first-page":"2376","volume":"1","author":"HW Shin","year":"2014","unstructured":"Shin HW, Jewells V, Hadar E, Fisher T, Hinn A (2014) Review of epilepsy-etiology, diagnostic evaluation and treatment. Int J Neurorehabilit 1:2376\u20130281","journal-title":"Int J Neurorehabilit"},{"key":"7755_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1570159X12666140923205715","volume":"12","author":"B Martinc","year":"2014","unstructured":"Martinc B, Grabnar I, Vovk T (2014) Antioxidants as a preventive treatment for epileptic process: a review of the current status. Curr Neuropharmacol 12:527\u2013550","journal-title":"Curr Neuropharmacol"},{"key":"7755_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0091-3057(03)00112-6","volume":"75","author":"E Carlini","year":"2003","unstructured":"Carlini E (2003) Plants and the central nervous system. Pharmacol Biochem Behav 75:501\u2013512","journal-title":"Pharmacol Biochem Behav"},{"key":"7755_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1078\/0944-7113-00050","volume":"8","author":"R Almeida","year":"2001","unstructured":"Almeida R, Navarro D, Barbosa-Filho J (2001) Plants with central analgesic activity. Phytomedicine 8:310\u2013322","journal-title":"Phytomedicine"},{"key":"7755_CR22","first-page":"3","volume":"2","author":"RDA N\u00f3brega","year":"2003","unstructured":"N\u00f3brega RDA, Motta SC, Leite JR (2003) \u00d3leos essenciais com propriedades anticonvulsivantes. Bol Latinoam y del Caribe de Plantas Med y Arom\u00e1t 2:3\u20136","journal-title":"Bol Latinoam y del Caribe de Plantas Med y Arom\u00e1t"},{"key":"7755_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.pbb.2003.11.004","volume":"77","author":"RN de Almeida","year":"2004","unstructured":"de Almeida RN, Motta SC, de Brito FC, Catallani B, Leite JR (2004) Anxiolytic-like effects of rose oil inhalation on the elevated plus-maze test in rats. Pharmacol Biochem Behav 77:361\u2013364","journal-title":"Pharmacol Biochem Behav"},{"key":"7755_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13596-019-00396-8","volume":"19","author":"M Kamal","year":"2019","unstructured":"Kamal M, Naz M, Jawaid T, Arif M (2019) Natural products and their active principles used in the treatment of neurodegenerative diseases: a review. Orient Pharm Exp Med 19:343\u2013365","journal-title":"Orient Pharm Exp Med"},{"key":"7755_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/nu9050477","volume":"9","author":"D Szwajgier","year":"2017","unstructured":"Szwajgier D, Borowiec K, Pustelniak K (2017) The neuroprotective effects of phenolic acids: molecular mechanism of action. Nutrients 9:477","journal-title":"Nutrients"},{"key":"7755_CR26","first-page":"72","volume":"80","author":"R Almeida","year":"1999","unstructured":"Almeida R (1999) Metodologia para avalia\u00e7\u00e3o de plantas com atividade no sistema nervoso central e alguns dados experimentais. Rev Bras Farm 80:72\u201376","journal-title":"Rev Bras Farm"},{"key":"7755_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.phymed.2007.09.018","volume":"15","author":"LJ Quintans-J\u00fanior","year":"2008","unstructured":"Quintans-J\u00fanior LJ, Souza T, Leite B, Lessa N, Bonjardim L, Santos M et al (2008) Phythochemical screening and anticonvulsant activity of Cymbopogon winterianus Jowitt (Poaceae) leaf essential oil in rodents. Phytomedicine 15:619\u2013624","journal-title":"Phytomedicine"},{"key":"7755_CR28","first-page":"207","volume":"26","author":"B Meldrum","year":"1981","unstructured":"Meldrum B (1981) GABA-agonists as anti-epileptic agents. Adv Biochem Psychopharmacol 26:207\u2013217","journal-title":"Adv Biochem Psychopharmacol"},{"key":"7755_CR29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.1992.tb06221.x","volume":"33","author":"K Gale","year":"1992","unstructured":"Gale K (1992) GABA and epilepsy: basic concepts from preclinical research. Epilepsia 33:S3-12","journal-title":"Epilepsia"},{"key":"7755_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00238730","volume":"23","author":"C Game","year":"1975","unstructured":"Game C, Lodge D (1975) The pharmacology of the inhibition of dorsal horn neurones by impulses in myelinated cutaneous afferents in the cat. Exp Brain Res 23:75\u201384","journal-title":"Exp Brain Res"},{"key":"7755_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0006-8993(97)01153-0","volume":"784","author":"S McGaraughty","year":"1998","unstructured":"McGaraughty S, Henry JL (1998) The effects of strychnine, bicuculline, and ketamine onimmersion-inhibited\u2019dorsal horn convergent neurons in intact and spinalized rats. Brain Res 784:63\u201370","journal-title":"Brain Res"},{"key":"7755_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.phymed.2007.04.007","volume":"16","author":"M Blanco","year":"2009","unstructured":"Blanco M, Costa C, Freire A, Santos J Jr, Costa M (2009) Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine 16:265\u2013270","journal-title":"Phytomedicine"},{"key":"7755_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00210-010-0494-9","volume":"381","author":"MR Silva","year":"2010","unstructured":"Silva MR, Ximenes RM, da Costa JGM, Leal LKA, de Lopes AA, de Barros Viana GS (2010) Comparative anticonvulsant activities of the essential oils (EOs) from Cymbopogon winterianus Jowitt and Cymbopogon citratus (DC) Stapf in mice. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 381:415\u201326","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"7755_CR34","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/ptr.6617","volume":"34","author":"A Dhir","year":"2020","unstructured":"Dhir A (2020) Natural polyphenols in preclinical models of epilepsy. Phytother Res 34:1268\u20131281","journal-title":"Phytother Res"},{"key":"7755_CR35","first-page":"557","volume":"13","author":"LCR Lins","year":"2014","unstructured":"Lins LCR, Santos IMA, dos Passos Menezes P, Sara\u00fajo AA, de Souza Nunes R, dos Santos MRV et al (2014) The anticonvulsant effect of geraniol and inclusion complex geraniol: B-cyclodextrin. Bol Latinoam y del Caribe de Plantas Med y Arom\u00e1t 13:557\u201365","journal-title":"Bol Latinoam y del Caribe de Plantas Med y Arom\u00e1t"},{"key":"7755_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1590\/S0102-695X2011005000124","volume":"21","author":"MS Melo","year":"2011","unstructured":"Melo MS, Santana MTd, Guimar\u00e3es AG, Siqueira RS, Sousa DPD, Santos R et al (2011) Bioassay-guided evaluation of central nervous system effects of citronellal in rodents. Rev Bras de Farmacogn 21:697\u2013703","journal-title":"Rev Bras de Farmacogn"},{"key":"7755_CR37","doi-asserted-by":"publisher","first-page":"153965","DOI":"10.1016\/j.phymed.2022.153965","volume":"98","author":"L Xu","year":"2022","unstructured":"Xu L, Liu M-Z, Yang Y-Y, Wang Y, Hua X-X, Du L-X et al (2022) Geraniol enhances inhibitory inputs to the paraventricular thalamic nucleus and induces sedation in mice. Phytomedicine 98:153965","journal-title":"Phytomedicine"},{"issue":"2","key":"7755_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sc.2012.158","volume":"52","author":"B Lee","year":"2012","unstructured":"Lee B, Cripps R, Fitzharris M, Wing P (2012) The global map for traumatic spinal cord injury epidemiology: expanding the online global repository: update 2011. Spinal Cord 52(2):110\u2013116","journal-title":"Spinal Cord"},{"key":"7755_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00586-015-3985-z","volume":"25","author":"M Majdan","year":"2016","unstructured":"Majdan M, Brazinova A, Mauritz W (2016) Epidemiology of traumatic spinal cord injuries in Austria 2002\u20132012. Eur Spine J 25:62\u201373","journal-title":"Eur Spine J"},{"key":"7755_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/neu.2006.23.318","volume":"23","author":"DC Baptiste","year":"2006","unstructured":"Baptiste DC, Fehlings MG (2006) Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23:318\u2013334","journal-title":"J Neurotrauma"},{"key":"7755_CR41","first-page":"264","volume":"23","author":"T Hagg","year":"2006","unstructured":"Hagg T, Oudega M (2006) Neural degeneration and regeneration myelin and scar-derived inhibition. J Neurotrauma 23:264\u2013280","journal-title":"J Neurotrauma"},{"key":"7755_CR42","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.3390\/ijerph120404116","volume":"12","author":"C-Y Kuo","year":"2015","unstructured":"Kuo C-Y, Liou T-H, Chang K-H, Chi W-C, Escorpizo R, Yen C-F et al (2015) Functioning and disability analysis of patients with traumatic brain injury and spinal cord injury by using the world health organization disability assessment schedule 2.0. Int J Environ Res Public Health 12:4116\u201327","journal-title":"Int J Environ Res Public Health"},{"key":"7755_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3892\/etm.2013.1371","volume":"7","author":"B Lin","year":"2014","unstructured":"Lin B, Xu Y, Zhang B, He Y, Yan Y, He MC (2014) MEK inhibition reduces glial scar formation and promotes the recovery of sensorimotor function in rats following spinal cord injury. Exp Ther Med 7:66\u201372","journal-title":"Exp Ther Med"},{"key":"7755_CR44","first-page":"351","volume":"34","author":"C Turbes","year":"1997","unstructured":"Turbes C (1997) Repair, reconstruction, regeneration and rehabilitation strategies to spinal cord injury. Biomed Sci Instrum 34:351\u2013356","journal-title":"Biomed Sci Instrum"},{"key":"7755_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2340\/16501977-0979","volume":"44","author":"W Reichenfelser","year":"2012","unstructured":"Reichenfelser W, Hackl H, Hufgard J, Kastner J, Gstaltner K, Gf\u00f6hler M (2012) Monitoring of spasticity and functional ability in individuals with incomplete spinal cord injury with a functional electrical stimulation cycling system. J Rehabil Med 44:444\u2013449","journal-title":"J Rehabil Med"},{"key":"7755_CR46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jpain.2014.02.005","volume":"15","author":"A Vuckovic","year":"2014","unstructured":"Vuckovic A, Hasan MA, Fraser M, Conway BA, Nasseroleslami B, Allan DB (2014) Dynamic oscillatory signatures of central neuropathic pain in spinal cord injury. J Pain 15:645\u2013655","journal-title":"J Pain"},{"key":"7755_CR47","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/sc.2013.105","volume":"51","author":"P Tederko","year":"2013","unstructured":"Tederko P, Krasuski M, Ptyushkin P, Selb M, Pawlak K, Skrzypczyk R et al (2013) Need for a comprehensive epidemiologic study of spinal cord injury in Poland: findings from a systematic review. Spinal cord 51:802\u2013808","journal-title":"Spinal cord"},{"key":"7755_CR48","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1139\/cjpp-2016-0528","volume":"95","author":"Y Lv","year":"2017","unstructured":"Lv Y, Zhang L, Li N, Mai N, Zhang Y, Pan S (2017) Geraniol promotes functional recovery and attenuates neuropathic pain in rats with spinal cord injury. Can J Physiol Pharmacol 95:1389\u20131395","journal-title":"Can J Physiol Pharmacol"},{"key":"7755_CR49","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.3892\/etm.2016.3850","volume":"12","author":"J Wang","year":"2016","unstructured":"Wang J, Su B, Zhu H, Chen C, Zhao G (2016) Protective effect of geraniol inhibits inflammatory response, oxidative stress and apoptosis in traumatic injury of the spinal cord through modulation of NF-\u03baB and p38 MAPK. Exp Ther Med 12:3607\u20133613","journal-title":"Exp Ther Med"},{"key":"7755_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.v62n0103","volume":"62","author":"N Sartorius","year":"2001","unstructured":"Sartorius N (2001) The economic and social burden of depression. J Clin Psychiatry 62:8\u201311","journal-title":"J Clin Psychiatry"},{"key":"7755_CR51","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990\u20132020: global burden of disease study. Lancet 349:1498\u20131504","journal-title":"Lancet"},{"key":"7755_CR52","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","volume":"63","author":"JH Meyer","year":"2006","unstructured":"Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A et al (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63:1209\u20131216","journal-title":"Arch Gen Psychiatry"},{"key":"7755_CR53","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M (2011) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 35:664\u2013675","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7755_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1185\/03007990802622726","volume":"25","author":"SH Kennedy","year":"2009","unstructured":"Kennedy SH, Andersen HF, Thase ME (2009) Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin 25:161\u2013175","journal-title":"Curr Med Res Opin"},{"key":"7755_CR55","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327:296\u2013300","journal-title":"Science"},{"key":"7755_CR56","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1017\/S1461145714000285","volume":"17","author":"M Lu","year":"2014","unstructured":"Lu M, Yang J-Z, Geng F, Ding J-H, Hu G (2014) Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesis. Int J Neuropsychopharmacol 17:1501\u20131510","journal-title":"Int J Neuropsychopharmacol"},{"key":"7755_CR57","first-page":"65","volume":"3","author":"C Sahin","year":"2013","unstructured":"Sahin C, Aricioglu F (2013) A novel aspect for depression and cytokine hypothesis:\\\u02b9NLRP3 Inflammasome\\\u02b9. Clin Exp Health Sci 3:65","journal-title":"Clin Exp Health Sci"},{"key":"7755_CR58","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.physbeh.2015.10.008","volume":"152","author":"X-Y Deng","year":"2015","unstructured":"Deng X-Y, Xue J-S, Li H-Y, Ma Z-Q, Fu Q, Qu R et al (2015) Geraniol produces antidepressant-like effects in a chronic unpredictable mild stress mice model. Physiol Behav 152:264\u2013271","journal-title":"Physiol Behav"},{"key":"7755_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bj.2018.08.008","volume":"41","author":"KAA Medeiros","year":"2018","unstructured":"Medeiros KAA, Dos Santos JR, Melo TCdS, de Souza MF, Santos LdG, de Gois AM et al (2018) Depressant effect of geraniol on the central nervous system of rats: behavior and ECoG power spectra. Biomed J 41:298\u2013305","journal-title":"Biomed J"},{"key":"7755_CR60","doi-asserted-by":"publisher","first-page":"e04708","DOI":"10.1016\/j.heliyon.2020.e04708","volume":"6","author":"MA Kandeil","year":"2020","unstructured":"Kandeil MA, Gomaa SB, Mahmoud MO (2020) The effect of some natural antioxidants against cisplatin-induced neurotoxicity in rats: behavioral testing. Heliyon 6:e04708","journal-title":"Heliyon"},{"key":"7755_CR61","volume-title":"An essay on the shaking palsy","author":"P James","year":"1817","unstructured":"James P (1817) An essay on the shaking palsy. Sherwood Neely and Jones, London"},{"key":"7755_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4784268","volume":"2018","author":"G Gelders","year":"2018","unstructured":"Gelders G, Baekelandt V, Van der Perren A (2018) Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease. J Immunol Res 2018:1\u201312","journal-title":"J Immunol Res"},{"key":"7755_CR63","first-page":"1003","volume":"1","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj D, Thangavel R, Natteru P, Selvakumar G, Saeed D, Zahoor H et al (2016) Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine 1:1003","journal-title":"J Neurol Neurosurg Spine"},{"key":"7755_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2009.03.006","volume":"218","author":"H B\u00fceler","year":"2009","unstructured":"B\u00fceler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson\u2019s disease. Exp Neurol 218:235\u2013246","journal-title":"Exp Neurol"},{"key":"7755_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gene.2013.07.085","volume":"532","author":"L Zuo","year":"2013","unstructured":"Zuo L, Motherwell MS (2013) The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson\u2019s disease. Gene 532:18\u201323","journal-title":"Gene"},{"key":"7755_CR66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp neurobiol 24:103","journal-title":"Exp neurobiol"},{"key":"7755_CR67","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","volume":"13","author":"A Gross","year":"1999","unstructured":"Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899\u20131911","journal-title":"Genes Dev"},{"key":"7755_CR68","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A Hartmann","year":"2000","unstructured":"Hartmann A, Hunot S, Michel PP, Muriel M-P, Vyas S, Faucheux BA et al (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci USA 97:2875\u20132880","journal-title":"Proc Natl Acad Sci USA"},{"key":"7755_CR69","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/ana.10489","volume":"53","author":"WG Tatton","year":"2003","unstructured":"Tatton WG, Chalmers-Redman R, Brown D, Tatton N (2003) Apoptosis in Parkinson\u2019s disease: signals for neuronal degradation. Annals Neurol 53:S61\u2013S72","journal-title":"Annals Neurol"},{"key":"7755_CR70","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1046\/j.1471-4159.2001.00160.x","volume":"76","author":"A Hartmann","year":"2001","unstructured":"Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M et al (2001) Is bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease? J Neurochem 76:1785\u20131793","journal-title":"J Neurochem"},{"key":"7755_CR71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuroscience.2011.10.031","volume":"199","author":"N Xiong","year":"2011","unstructured":"Xiong N, Jia M, Chen C, Xiong J, Zhang Z, Huang J et al (2011) Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y. Neuroscience 199:292\u2013302","journal-title":"Neuroscience"},{"key":"7755_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.freeradbiomed.2013.05.014","volume":"63","author":"M Dodson","year":"2013","unstructured":"Dodson M, Darley-Usmar V, Zhang J (2013) Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic Biol Med 63:207\u2013221","journal-title":"Free Radic Biol Med"},{"key":"7755_CR73","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20111451","volume":"441","author":"J Lee","year":"2012","unstructured":"Lee J, Giordano S, Zhang J (2012) Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 441:523\u2013540","journal-title":"Biochem J"},{"key":"7755_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.redox.2012.11.008","volume":"1","author":"J Zhang","year":"2013","unstructured":"Zhang J (2013) Autophagy and mitophagy in cellular damage control. Redox Biol 1:19\u201323","journal-title":"Redox Biol"},{"key":"7755_CR75","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"7755_CR76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00401-011-0815-1","volume":"121","author":"J Zhou","year":"2011","unstructured":"Zhou J, Broe M, Huang Y, Anderson JP, Gai W-P, Milward EA et al (2011) Changes in the solubility and phosphorylation of \u03b1-synuclein over the course of Parkinson\u2019s disease. Acta Neuropathol 121:695\u2013704","journal-title":"Acta Neuropathol"},{"key":"7755_CR77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10072-008-0986-2","volume":"29","author":"H Yokoyama","year":"2008","unstructured":"Yokoyama H, Kuroiwa H, Yano R, Araki T (2008) Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson\u2019s disease. Neurol Sci 29:293\u2013301","journal-title":"Neurol Sci"},{"key":"7755_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01244987","volume":"76","author":"W Brooks","year":"1989","unstructured":"Brooks W, Jarvis M, Wagner G (1989) Astrocytes as a primary locus for the conversion MPTP into MPP+. J Neural Transm 76:1\u201312","journal-title":"J Neural Transm"},{"key":"7755_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V (2005) The MPTP model of Parkinson\u2019s disease. Mol Brain Res 134:57\u201366","journal-title":"Mol Brain Res"},{"key":"7755_CR80","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"C Olanow","year":"1999","unstructured":"Olanow C, Tatton W (1999) Etiology and pathogenesis of Parkinson\u2019s disease. Annu Rev Neurosci 22:123\u2013144","journal-title":"Annu Rev Neurosci"},{"key":"7755_CR81","first-page":"35","volume":"13","author":"S Przedborski","year":"1998","unstructured":"Przedborski S, Jackson-Lewis V (1998) Mechanisms of MPTP toxicity. Move disord 13:35\u201338","journal-title":"Move disord"},{"key":"7755_CR82","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S et al (2001) Oxidative post-translational modifications of \u03b1-synuclein in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease. J Neurochem 76:637\u2013640","journal-title":"J Neurochem"},{"key":"7755_CR83","doi-asserted-by":"publisher","first-page":"S453","DOI":"10.3233\/JAD-2010-100321","volume":"20","author":"GC Higgins","year":"2010","unstructured":"Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P (2010) Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimer\u2019s Dis 20:S453\u2013S473","journal-title":"J Alzheimer\u2019s Dis"},{"key":"7755_CR84","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbadis.2008.10.005","volume":"1792","author":"K-L Lim","year":"2009","unstructured":"Lim K-L, Ng C-H (2009) Genetic models of Parkinson disease. Biochim et Biophys Acta (BBA)-Mol Basis of Dis 1792:604\u201315","journal-title":"Biochim et Biophys Acta (BBA)-Mol Basis of Dis"},{"key":"7755_CR85","doi-asserted-by":"publisher","first-page":"R713","DOI":"10.1016\/j.cub.2017.05.064","volume":"27","author":"NJ Vickers","year":"2017","unstructured":"Vickers NJ (2017) Animal communication: when i\u2019m calling you, will you answer too? Curr Biol 27:R713\u2013R715","journal-title":"Curr Biol"},{"key":"7755_CR86","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cbi.2010.01.034","volume":"184","author":"X Wang","year":"2010","unstructured":"Wang X, Ye X-l, Liu R, Chen H-L, Bai H, Liang X et al (2010) Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chemico-Biol Interact 184:328\u201337","journal-title":"Chemico-Biol Interact"},{"key":"7755_CR87","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s12031-013-0074-9","volume":"51","author":"KR Rekha","year":"2013","unstructured":"Rekha KR, Selvakumar GP, Sethupathy S, Santha K, Sivakamasundari RI (2013) Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson\u2019s disease. J Mol Neurosci 51:851\u2013862","journal-title":"J Mol Neurosci"},{"key":"7755_CR88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cbi.2010.07.009","volume":"188","author":"M Luo","year":"2010","unstructured":"Luo M, Liu X, Zu Y, Fu Y, Zhang S, Yao L et al (2010) Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chemico-Biol Interact 188:151\u201360","journal-title":"Chemico-Biol Interact"},{"key":"7755_CR89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphar.2016.00038","volume":"7","author":"L De Fazio","year":"2016","unstructured":"De Fazio L, Spisni E, Cavazza E, Strillacci A, Candela M, Centanni M et al (2016) Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice. Front Pharmacol 7:38","journal-title":"Front Pharmacol"},{"key":"7755_CR90","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3892\/ijo.2016.3427","volume":"48","author":"M ChO","year":"2016","unstructured":"ChO M, So I, Chun JN, Jeon J-H (2016) The antitumor effects of geraniol: modulation of cancer hallmark pathways. Int J Oncol 48:1772\u20131782","journal-title":"Int J Oncol"},{"key":"7755_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fphar.2018.00018","volume":"9","author":"B Pavan","year":"2018","unstructured":"Pavan B, Dalpiaz A, Marani L, Beggiato S, Ferraro L, Canistro D et al (2018) Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes. Front Pharmacol 9:18","journal-title":"Front Pharmacol"},{"key":"7755_CR92","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jconrel.2020.02.033","volume":"321","author":"ER de Oliveira Junior","year":"2020","unstructured":"de Oliveira Junior ER, Truzzi E, Ferraro L, Fogagnolo M, Pavan B, Beggiato S et al (2020) Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: towards a new approach for the management of Parkinson\u2019s disease. J Control Release 321:540\u2013552","journal-title":"J Control Release"},{"key":"7755_CR93","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s11064-018-2617-5","volume":"43","author":"KR Rekha","year":"2018","unstructured":"Rekha KR, Sivakamasundari RI (2018) Geraniol protects against the protein and oxidative stress induced by rotenone in an in vitro model of Parkinson\u2019s disease. Neurochem Res 43:1947\u20131962","journal-title":"Neurochem Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07755-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07755-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07755-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:38:37Z","timestamp":1667133517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07755-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":93,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7755"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07755-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agree to publish the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}